• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ZIOPHARM Oncology Inc

+ Add to Watchlist

ZIOP:US

4.8000 USD 0.5300 12.41%

As of 20:10:00 ET on 12/19/2014.

Snapshot for ZIOPHARM Oncology Inc (ZIOP)

Open: 4.3000 Day's Range: 4.2700 - 4.8400 Volume: 2,150,375
Previous Close: 4.2700 52wk Range: 2.3100 - 5.5800 1-Yr Rtn: +20.00%

Stock Chart for ZIOP

No chart data available.
  • ZIOP:US 4.8000
  • 1D
  • 1M
  • 1Y
4.2700
Interactive ZIOP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ZIOP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3025
Est. EPS (USD) (12/2014) -0.4400
Est. PEG Ratio -
Market Cap (M USD) 493.02
Shares Outstanding (M) 102.71
30 Day Average Volume 995,114
Price/Book (mrq) 13.5158
Price/Sale (ttm) 386.9144
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/03/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ZIOP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ZIOP

ZIOPHARM Oncology, Inc. is a biopharmaceutical company seeking to acquire, develop and commercialize a diverse, risk-sensitive portfolio of in-licensed cancer drugs.

Jonathan J LewisChief Executive OfficerCaesar J BelbelExec VP/Chief Legal Ofcr/Secy
Kevin G LafondVP:Finance/Chief Accounting Ofcr
More Company Profile & Key Executives for ZIOP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil